Showing results (71-80 of 146) with videos related to

Sort By:
Pageof 15
Hematology/Oncology and Stem Cell Therapy|October 21, 2019
Ten-year survival outcomes for patients with early stage classical Hodgkin lymphoma: An analysis from Kentucky Cancer RegistryZin W Myint, Runa Shrestha, Salahuddin Siddiqui, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|March 15, 2011
Isolated cerebral manifestation of Epstein-Barr virus-associated post-transplant lymphoproliferative disorder after allogeneic hematopoietic stem cell transplantation: a case of clinical and diagnostic challengesN A Kittan, F Beier, K Kurz, et al.
Cytokine|September 2, 2009
G to C transition at position -173 of MIF gene of the recipient is associated with reduced relapse rates after allogeneic stem cell transplantationYa-Yi Chang, Hildegard T Greinix, Anne M Dickinson, et al.
Blood|November 18, 2004
Donor T-cell production of RANTES significantly contributes to the development of idiopathic pneumonia syndrome after allogeneic stem cell transplantationGerhard C Hildebrandt, Krystyna M Olkiewicz, Sung Choi, et al.
Frontiers in Immunology|November 5, 2019
Mast Cells Are Mediators of Fibrosis and Effector Cell Recruitment in Dermal Chronic Graft-vs.-Host DiseaseEthan Strattan, Senthilnathan Palaniyandi, Reena Kumari, et al.
European Journal of Pharmacology|January 29, 2000
The novel pyridoxal-5'-phosphate derivative PPNDS potently antagonizes activation of P2X(1) receptorsG Lambrecht, J Rettinger, H G Bäumert, et al.
International Journal of Hematology|March 17, 2009
Preventive usage of broad spectrum chemokine inhibitor NR58-3.14.3 reduces the severity of pulmonary and hepatic graft-versus-host diseaseSandra Miklos, Gunnar Mueller, Yayi Chang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 3, 2014
Preventive azithromycin treatment reduces noninfectious lung injury and acute graft-versus-host disease in a murine model of allogeneic hematopoietic cell transplantationSabarinath Venniyil Radhakrishnan, Senthilnathan Palaniyandi, Gunnar Mueller, et al.
Transplantation|October 22, 2019
TNFAIP8 Deficiency Exacerbates Acute Graft Versus Host Disease in a Murine Model of Allogeneic Hematopoietic Cell TransplantationReena Kumari, Senthilnathan Palaniyandi, Ethan Strattan, et al.
Haematologica|August 30, 2023
Lisocabtagene maraleucel for second-line relapsed or refractory large B-cell lymphoma: patient-reported outcomes from the PILOT studyLeo I Gordon, Fei Fei Liu, Julia Braverman, et al.
Pageof 15